Guyu Zeng, Pei Zhu, Deshan Yuan, Peizhi Wang, Tianyu Li, Qinxue Li, Jingjing Xu, Xiaofang Tang, Ying Song, Yan Chen, Ce Zhang, Sida Jia, Ru Liu, Lin Jiang, Lei Song, Runlin Gao, Yuejin Yang, Xueyan Zhao, Jinqing Yuan
BACKGROUND AND HYPOTHESIS: Lipoprotein(a) [Lp(a)] and renal dysfunction are both independent risk factors for cardiovascular disease. However, it remains unclear whether renal function mediates the association between Lp(a) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention (PCI). METHODS: From a large prospective cohort study, 10 435 eligible patients undergoing PCI from January 2013 to December 2013 were included in our analysis...
March 2024: Clinical Kidney Journal